Summary: Hepatic microsomes from human liver catalyzed oxidation of the allyl aldehydes such as 11-oxo-D 8 -tetrahydrocannabinol and 9-anthraldehyde to the corresponding carboxylic acid metabolites. The oxygenation mechanism was conˆrmed by GC-MS that molecular oxygen was exclusively incorporated into D 8 -tetrahydrocannabinol-11-oic acid and 9-anthracene carboxylic acid formed under oxygen-18 gas. The microsomal aldehyde oxygenase (named MALDO) activities of 11-oxo-D 8 -tetrahydrocannabinol and 9-anthraldehyde were signiˆcantly inhibited by the antibody against CYP2C and CYP3A, respectively. MALDO activity for 11-oxo-D 8 -tetrahydrocannabinol was signiˆcantly inhibited by sulfaphenazole whereas that for 9-anthraldehyde was markedly inhibited by troleandomycin, but not by sulfaphenazole. CYP2C9 expressed in human B-lymphoblastoid cells catalyzed e‹ciently the MALDO activity for 11-oxo-D 8 -tetrahydrocannabinol (10.1 nmol W min W nmol P450), while the catalytic activities of other human CYPs expressed in the cells were lesser extents. In MALDO activity for 9-anthraldehyde, CYP3A4 expressed in the cells had the highest catalytic activity (7.72 nmol W min W nmol P450). These results indicate that CYP2C9 and CYP3A4 are major enzymes responsible for the MALDO activity in human liver for 11-oxo-D 8 -tetrahydrocannabinol and 9-anthraldehyde, respectively.
Introduction
Aldehydes are intermediate metabolites from alcohol to carboxylic acids in the biological system. They are also formed during as products of lipid peroxidation. 1) Some of aldehydes are cytotoxic and mutagenic in experiments. 2, 3) We previously reported that 11-oxo-D 8 -tetrahydrocannabinol (11-oxo-D 8 -THC), which is an intermediate metabolite 4) of D 8 -THC, a psychoactive component of marijuana, showed potent pharmacological eŠects such as catalepsy, hypothermia and pentobarbital-induced sleep prolongation. 5) In general, aldehydes are known to be metabolized mainly to carboxylic acids by aldehyde dehydrogenase, which is mainly located in the mitochondria and cytosol.
Previous studies from our laboratory demonstrated that hepatic microsomes from mice and rats were capable to oxidize 11-oxo-D 8 -THC to D 8 -THC-11-oic acid. 6) We also demonstrated that the microsomal aldehyde oxygenase (MALDO) catalyzed the oxidation of various aldehyde substrates to the corresponding carboxylic acids. 7) Among aldehydes examined, 11-oxo-D 8 -THC and 9-anthraldehyde (9-AA) are good substrates for the microsomal aldehyde oxygenation (Fig. 1) . Cytochrome P450 (CYP) has been reported to be involved in the MALDO activity of 11-oxo-D 8 -THC in mouse and rat livers. 8, 9) CYP2C11 was also reported to be the major enzyme of 9-AA MALDO activity in male rat liver. 10) In addition, the authors also reported that cyp2c29 11) and CYP2C11 12) were major enzymes for 11-hydroxylation of D 8 -THC in hepatic microsomes from mice and male rats, respectively. More recently, Terelius et al. 13) and Roberts et al. 14) reported that puriˆed CYPs catalyzed the oxidation of acetaldehyde and retinal, respectively, to the corresponding carboxylic acids. Cyp 2c29 8) and CYP2C11 9) have been shown as major enzymes responsible for MALDO activity of 11-oxo-D 8 -THC in mouse and rat livers, respectively. These results indicate that the catalytic activity of CYP to oxidize aldehydes to carboxylic acids is a general function of the enzyme. In human liver, little is known about major CYP enzymes responsible for microsomal aldehyde oxygenation. The present study described major CYP enzymes for microsomal oxygenation of 11-oxo-D 8 -THC and 9-AA in human liver.
Materials and Methods
Cannabinoids and other chemicals: 11-Oxo-D 8 -THC, 15 ) D 8 -THC-11-oic acid 16) and 5?-nor-D 8 -THC-4?-oic acid 17) were prepared by the methods described previously. The purities of these cannabinoids were determined to be at least 95z by gas chromatography. NADP and glucose-6-phosphate were purchased from Boehringer-Mannheim GmbH (Darmstadt, F.R.G. Enzyme source: Hepatic microsomes were prepared from the human livers of a 57-year-old woman (HL-1) and 16 year-old man (HL-2) who were killed in tra‹c accidents. The use of the human liver for experiments was approved by Ethics Committee of Kanazawa University, Faculty of Medicine. Human hepatic microsomes were prepared by the method reported previously.
18) The human CYPs (1A1, 1A2, 2A6, 2B6, 2C8, 2C9-Arg144 (2C9-Arg), 2C19, 2D6-Met374 (2D6-Met), 2D6-Val374 (2D6-Val), 2E1 and 3A4) containing microsomes prepared from human B-lymphoblastoid cells expressed cDNA and control microsomes (with or without vector) were purchased from Gentest Corporation (Woburn, MA, USA).
Measurement of MALDO activities: 1) 11-Oxo-D 8 -THC as a substrate The enzymatic activity was measured as previously reported.
9) 11-Oxo-D 8 -THC (60 mM) was incubated with the human hepatic microsomes (0.5 mg protein) or the human B-lymphoblastoid cell microsomes (0.5 mg protein), an NADPH-generating system (0.5 mM NADP, 10 mM glucose-6-phosphate, 10 mM MgCl2 and 1 unit glucose 6-phosphate dehydrogenase) and 100 mM sodium-potassium phosphate buŠer (pH 7.4) to make â nal volume of 0.5 mL. The mixture was incubated at 379 C for 20 min and then extracted with 5 mL of ethyl acetate after addition of 5?-nor-D
8
-THC-4?-oic acid as an internal standard. A portion of the extract was evaporated to dryness, and D 8 -THC-11-oic acid formed was derivatized to methyl ester and trimethylsilylether. The metabolite was determined by GC W MS. 9) 2) 9-Anthraldehyde (9-AA) as a substrate The enzymatic activity was measured as reported previously. 19) 9-AA was incubated with the same conditions as described for 11-oxo-D 8 -THC. The reaction was terminated by the addition of 1 mL of 0.5 N NaOH. The reaction mixture was extracted with 4 mL of ethyl acetate and then the aqueous layer (1 mL) was transferred to another tube. 9-Anthracene carboxylic acid (9-ACA) formed was extracted with 4 mL of ethyl acetate after the addition of 1 mL 0.5 N HCl. Fluorescence intensity in the organic layer was measured with a Hitachi 850 ‰uorometer at excitation and emission wavelengths of 255 and 458 nm, respectively. The experiments under oxygen-18 gas carried out as reported previously.
6) The incubation system as the same as above using the incubation tube covered with a silicon cap. After evacuation and introduction of oxygen-18 gas (97 atomz) by a gas syringe, the reaction was initiated by the injection of the substrate into the incubation tube. The reaction mixture was incubated at 379 C for 30 min and the metabolites formed were analyzed by GC W MS. 7, 9) Inhibitory eŠects of various inhibitors on MALDO activities: Human hepatic microsomes were incubated with 11-oxo-D 8 -THC and 9-AA under the same manner as above, together with sulfaphenazole (10 mM), 7,8-benzo‰avone (10 mM) or troleandomycin (100 mM). In the case of troleandomycin, the incubation mixture without substrate was preincubated at 379 C for 20 min and the reaction was initiated by the addition of substrate (11-oxo-D 8 -THC or 9-AA) and a further aliquot of NADPH-generating system.
20)
Inhibitory eŠects of antibodies against various CYPs: Polyclonal antibodies against rat CYPs 1A1, 1A2, 2B1, 2C11, 2D1, 2E1, 3A2 and 4B1 were raised in New Zealand white rabbits as described previously.
21) The antibodies were added to reaction mixture containing human hepatic microsomes (antiserum (mg) W microsomal protein (mg)＝10) and 100 mM sodium-potassium phosphate buŠer (pH 7.4) and preincubated at 379 C for 30 min. The substrate was added to the mixture, and the reaction was initiated by adding NADPH-generating system. The enzymatic activities were determined as described above.
Other methods: Protein concentration was determined by the method of Lowry et al. 22) using bovine serum albumin as a standard.
Results

Metabolism of 11-oxo-D
8 -THC and 9-AA with human hepatic microsomes and CYPs expressed in microsomes of human B-lymphoblastoid cells: MALDO activities for 11-oxo-D 8 -THC in human hepatic microsomes (HL-1 and HL-2) were 0.12 and 0.10 nmol W min W mg protein, respectively, whereas those for 9-AA were 0.50 and 0.25 nmol W min W mg protein, respectively. The catalytic activities of human CYPs were studied in human B-lymphoblastoid cell microsomes containing cDNA expressed CYPs 1A1, 1A2, 2A6, 2B6, 2C8, 2C9-Arg, 2C19, 2D6-Val, 2D6-Met, 2E1 and 3A4 ( Table 1) . Among the human CYPs examined, CYP2C9-Arg and 3A4 showed the highest activity for 11-oxo-D 8 -THC and 9-AA, respectively. The MALDO activity was not detected in the microsomes from control cells without CYPs. The MALDO activity for 11-oxo-D 8 -THC of CYPs 1A1, 2C8, 2C19, 2D6-Val and 3A4 were 0.57, 1.09, 1.85, 0.37 and 0.85 nmol W min W nmol P450, respectively. The MALDO activity of CYPs 1A2, 2A6, 2B6, 2D6-Met and 2E1 was negligible (º0.2 nmol W min W nmol P450). The MALDO activities for 9-AA of CYPs 1A1, 2A6, 2B6, 2D6-Met and 2E1 were 0.44, 0.29, 0.65, 0.08 and 0.08 nmol W min W nmol P450, respectively, whereas the MALDO activity by CYPs 1A2, 2C8, 2C9-Arg, 2C19 and 2D6-Val was negligible.
EŠects of inhibitors and anti-CYP antibodies on MALDO activity: The MALDO activity for 11-oxo-D 8 -THC in human liver (HL-1) was markedly inhibited by sulfaphenazole at 10 mM (82z inhibition), a selective inhibitor for CYP2C, 23, 24) whereas other inhibitors failed to a signiˆcant inhibition (Fig. 2) . The MALDO activity for 9-AA in the human hepatic microsomes was signiˆcantly inhibited by troleandomycin at 100 mM (74z inhibition), a selective inhibitor of CYP3A. 23, 25) Other inhibitors did not show a signiˆcant inhibition. 7,8-Benzo‰avone (10 mM), which is a speciˆc inhibitor of CYP1A 23, 25) and known to increase CYP3A activity at a particular concentration, 26) showed rather stimulation (59z) of the MALDO activity for 9-AA. EŠects of antibodies against rat CYPs on the MALDO activities in human hepatic microsomes are shown in Table 2 . The MALDO activity of 11-oxo-D 8 -THC and 9-AA were signiˆcantly inhibited by antibodies against CYPs 3A2 and 2C11, respectively. Both enzymatic activities were inhibited to about 20z of the control level when the antibody was added 10 fold of the microsomal protein.
None of the antibodies against other CYPs inhibited signiˆcantly the MALDO activity for 11-oxo-D 8 -THC and 9-AA.
Oxygenation mechanism of metabolism of 11-oxo-D 8 -THC and 9-AA to the corresponding carboxylic acid metabolites by human hepatic microsomes: 11-Oxo-D 8 -THC and 9-AA were metabolized with human hepatic microsomes (HL-1) under oxygen-18 gas (97 atomz). Human hepatic microsomes (HL-1) were incubated with 11-oxo-D
8
-tetrahydrocannabinol and 9-anthraldehyde, and troleandmycin (100 mM), 7,8-benzo‰avone (10 mM) or sulfaphenazole (10 mM). MALDO activities for 11-oxo-D 8 -tetrahydrocannabinol and 9-anthraldehyde are 0.11 and 0.45 nmol W min W mg protein, respectively, in the control. Each value is the mean of two to three determinations. Hepatic microsomes from HL-1 were used in the experiments.
MALDO Activity in Human Liver
The carboxylic acid metabolites formed were analyzed by GC W MS after the derivatization to methyl ester and TMS ether ( Table 3 ). The relative abundance of molecular ions at mW z 430 and 432 of D 8 -THC-11-oic acid derivative formed from 11-oxo-D 8 -THC was 5:100, and those at m W z 236 and 238 of 9-ACA formed from 9-AA was 8:100. These results indicate that molecular oxygen was exclusively incorporated into the carboxylic acid metabolites formed from the aldehyde substrate.
Discussion
Previous studies have shown that hepatic microsomes of various animal species catalyzed the oxidation of aldehydes to carboxylic acids by oxygenation mechanism. 11-Oxo-D 8 -THC and 9-AA have been reported to be oxidized to the corresponding carboxylic acids by microsomes from mouse and rat livers. 6, 8, 9, 19) Relatively few data are available on the contribution of a particular form of CYPs for metabolic steps of THC, although extensive studies have been reported on the metabolism of the cannabinoid in humans. 27, 28) Bornheim et al. 29) reported that CYP2C9 and CYP3A catalyzed the 11-hydroxylation and 8 b-hydroxylation, respectively, of D 9 -THC in human hepatic microsomes. We previously reported that human hepatic microsomes could catalyze the oxidation of 11-oxo-D 8 -THC to D 8 -THC-11-oic acid.
18) The present study demonstrated that human hepatic microsomes catalyzed the oxidation of 9-AA to 9-ACA as is the case of 11-oxo-D 8 -THC. Oxygenation mechanism for the oxidation of 11-oxo-D 8 -THC and 9-AA to the corresponding carboxylic acids was conrmed by incorporation of molecular oxygen from oxygen-18 gas. The present study further demonstrated that all CYP2Cs enzymes expressed in human B-lymphoblastoid cells showed the catalytic activity of the oxidation of 11-oxo-D Our previous studies showed that CYP2C11 and CYP2B were major CYPs responsible for the oxidation of 9-AA in hepatic microsomes of rat 10) and monkey, 30) respectively. In the present study, CYP3A4 exhibited the highest MALDO activity for 9-AA among human CYPs expressed in human B-lymphoblastoid cells and the enzymatic activities of other CYPs examined were less than 10z of CYP3A4. Troleandomycin, a speciˆc inhibitor of CYP3A, almost completely inhibited the MALDO activity in human hepatic microsomes.
CYP3A4 has been reported to be a major CYP in human liver. 26) The highest inhibition of the 9-AA MALDO activity by anti-3A antibody supports the idea that CYP3A4 is mainly contributed to the MALDO activity in human hepatic microsomes. Roberts et al. 14) reported that retinal was oxidized to retinoic acid by CYPs 1A2 and 3A6 puriˆed from rabbit hepatic microsomes in which the former was 5 times more active than the latter. These results indicate that the subfamily of CYP enzymes for aldehyde oxidation is dependent on the substrates used, although all of CYP enzymes responsible for the oxidation of 11-oxo-D 8 -THC claried (mouse, rat and human) are CYP2C enzymes. The present results also conˆrmed that the oxygenation of aldehydes is common property of CYP enzymes.
The present study conclusively demonstrated that CYP2C9 and CYP3A4 are major enzymes responsible for the MALDO activity of 11-oxo-D 8 -THC and 9-AA, respectively, in human liver.
